Phase 2 data for efdoralprin alfa demonstrate the recombinant protein maintains normal protein levels with less frequent dosing than current standards of care for patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema.
Phase 2 data for efdoralprin alfa demonstrate the recombinant protein maintains normal protein levels with less frequent dosing than current standards of care for patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema.
Read More
Researchers used machine learning to identify a unique new subtype of COPD: the emphysema inflammatory subgroup (EIS), which differs from other COPD subtypes in its immune profile and a more distinctive form of emphysema.
Read More
Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in a phase 2 clinical trial for adults with alpha-1 antitrypsin deficiency emphysema.
Read More
For patients receiving endobronchial valve procedures, high-volume hospitals had significantly longer lengths of stay.
Read More
Lung volume reduction surgery may provide better survival rates and fewer complications compared to endobronchial valve placement in severe emphysema patients.
Read More
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has posted a draft of its annual 2025 GOLD Report on COPD diagnosis, management, and prevention.
Read More
The effects of the gut microbiome on our health are far-reaching—research shows that even our lungs are influenced by this community of microbes.
Read More
Researchers found ‘statistically significant improvements’ in lung function, respiratory symptoms, and quality of life measures at 24 months.
Read More
New research challenges the common belief about marijuana’s harmlessness, exploring its combined effects with cigarette smoking on lung health.
Read More
Northwestern Medicine’s Palos Hospital recently conducted its first endobronchial valve procedure using Pulmonx’s Zephyr EBV system.
Read More
The new guide can assist providers in learning and practicing skills to prevent or manage respiratory symptoms in patients with chronic lung disease.
Read More
Chinese scientists have created a model alveolar system that mimics the breathing action of the human lung and allows visualization of flow patterns within the alveoli.
Read More
Among emphysema patients who were former smokers, a greater number of COPD exacerbations was associated with a greater loss of lung density.
Read More
Rural COPD patients face higher death rates; the first step to helping these patients is understanding why these disparities exist.
Read More
The first randomized controlled trial to compare lung volume reduction surgery and bronchoscopic lung volume reduction (BVLR) via endobronchial valves for people with emphysema has found that both lead to similar improvements in lung function, breathlessness, and exercise capacity.
Read More
A significant percentage of Black men found to have normal lung function after race-based adjustments to spirometry were actually found to have emphysema on their CT scans, according to research presented at ATS 2022.
Read More
Long-term cannabis smoking leads to over-inflated lungs, increased airway resistance and impaired oxygen extraction, which may reflect the early signs of a severe form of emphysema.
Read More
Bronchoscopy plays a role in both diagnosis and treatment of lung disease and recent advances in the procedure have greatly enhanced the usefulness of the fiberoptic bronchoscope.
Read More
Medical Mutual of Ohio updated its coverage to include the Spiration Valve System for eligible patients suffering from severe emphysema.
Read More
Characterizing the immune responses associated with emphysema may inform earlier and more personalized treatment approaches for COPD.
Read More
In patients with emphysema, the deposition fraction showed a strong correlation with diffusing...
Read More
A new multicenter study at Columbia University links long-term exposure to air pollution,...
Read More
Lung volume reduction procedures, which include endobronchial coils, valves or surgery, help improve lung function in COPD patients but do increase risk of adverse events.
Read More
The Zephyr Endobronchial Valve is the first minimally-invasive device approved in the United States for treating patients with severe emphysema.
Read More
